Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
Abstract Objectives: Cancer cachexia (CCA) is an intractable and ineffective metabolic syndrome that attacks 50–80% of cancer patients. It reduces…
Abstract Objectives: Cancer cachexia (CCA) is an intractable and ineffective metabolic syndrome that attacks 50–80% of cancer patients. It reduces…
Abstract This chapter provides an in-depth discussion of the legal and regulatory frameworks surrounding cannabis in the United States, including…
Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder of adult onset in the United States. It is…
Abstract Cannabis legalization has led to significant health consequences, particularly to patients in emergency departments and hospitals in Colorado. The…
Abstract Purpose: There have been a growing number of leadership education programs for physicians. However, debates about the value and…
Abstract Background: Cannabidiol (CBD) is a natural component of cannabis that possesses a widespread and complex immunomodulatory, antioxidant, anxiolytic, and…
Abstract The endocannabinoid (eCB) system has been implicated in a variety of physiological functions due to abundant expression of its…
Abstract Background: Lately, the number of people using marijuana in the USA has dramatically increased. In 2018, many states have…
Abstract Objective: Neuropathic pain is a common presenting complaint of patients with peripheral neuropathy (PN) and is considered one of…
Abstract Progressive deterioration of male reproductive function is occurring in Western countries. Environmental factors and unhealthy lifestyles have been implicated…